These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8863352)

  • 1. An outbreak of mumps in a population partially vaccinated with the Rubini strain.
    Germann D; Ströhle A; Eggenberger K; Steiner CA; Matter L
    Scand J Infect Dis; 1996; 28(3):235-8. PubMed ID: 8863352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)].
    Chamot E; Toscani L; Egger P; Germann D; Bourquin C
    Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. The Benevento and Compobasso Pediatricians Network for the Control of Vaccine-Preventable Diseases.
    Vaccine; 1998 May; 16(8):818-22. PubMed ID: 9627939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of Rubini, Jeryl-Lynn and Urabe mumps vaccine in an Asian population.
    Ong G; Goh KT; Ma S; Chew SK
    J Infect; 2005 Nov; 51(4):294-8. PubMed ID: 16291282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
    Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
    Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mumps epidemiology in Switzerland: results from the Sentinella surveillance system 1986-1993. Sentinella Work Group].
    Zimmermann H; Matter HC; Kiener T
    Soz Praventivmed; 1995; 40(2):80-92. PubMed ID: 7747525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the efficacy of various strains of mumps vaccine: a school survey].
    Toscani L; Batou M; Bouvier P; Schlaepfer A
    Soz Praventivmed; 1996; 41(6):341-7. PubMed ID: 9027138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain.
    Goh KT
    Lancet; 1999 Oct; 354(9187):1355-6. PubMed ID: 10533868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000.
    Utz S; Richard JL; Capaul S; Matter HC; Hrisoho MG; Mühlemann K
    J Med Virol; 2004 May; 73(1):91-6. PubMed ID: 15042654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of two mumps vaccines during an outbreak in Switzerland in 1999 and 2000: a case-cohort study.
    Richard JL; Zwahlen M; Feuz M; Matter HC;
    Eur J Epidemiol; 2003; 18(6):569-77. PubMed ID: 12908724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
    Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
    Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and vaccine efficiency.
    Schlegel M; Vernazza PL
    Vaccine; 1998 Aug; 16(13):1256. PubMed ID: 9682387
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G; Peña B; Marimón JM; Pérez-Trallero E
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.